November 28, 2025

With a Humboldt Professorship to Universität Heidelberg

With a Humboldt Professorship to Universität Heidelberg

International research prize goes to immunologist Jan Rehwinkel as nominated by Ruperto Carola

In order to boost the research field of immunology as a key biomedical discipline at Heidelberg University, Prof. Dr Jan Rehwinkel is receiving a Humboldt Professorship worth five million euros. Leading international academics are granted such a professorship to encourage them to conduct long-term, cutting-edge research at German universities. The professorship is awarded by the Alexander von Humboldt Foundation and financed by the Federal Ministry of Research, Technology and Space. At the Institute for Immunology of the Medical Faculty Heidelberg, Prof. Rehwinkel will, in collaboration with the Heidelberg life sciences, work on mechanisms of immune response activation. The goal is to decode the responses to infection, and to non-infectious damage to cells and tissues, on the molecular level and use the findings for therapeutic applications. At present, the immunologist, whom Ruperto Carola nominated for this most valuable international research prize in Germany, is working at the Weatherall Institute of Molecular Medicine at the University of Oxford (United Kingdom); there he heads the research group for nucleic acid sensing.

Porträt Jan Rehwinkel
Jan Rehwinkel | © privat

Prof. Rehwinkel’s research is at the interface of immunology, virology and molecular biology. In the context of viral infections, the scientist is studying a number of proteins that serve as molecular “antennas”. Through the immune receptors of the innate immune system, cells detect that they have been attacked and infected. Prof. Rehwinkel is investigating the question of how these sensors activate the body’s immune system when a virus invades the body. Since cells sense infection, inter alia, through identifying unusual nucleic acids, one focus of his work is on detecting modified or foreign RNA and DNA. Jan Rehwinkel studies the signaling pathways activated by nucleic acid sensing and investigates how these signals are transmitted to nearby cells with the help of cytokines and so-called immunotransmitters. Prof. Rehwinkel’s team also does research into the processes that prevent excessive activation of these signals and thus a misregulation of the immune system. A better understanding of nucleic acid detection may help in developing new antiviral strategies, explaining mechanisms of autoimmune diseases, and providing starting points for innovative cancer therapies that manipulate the immune responses to tumors in a targeted manner.

With Jan Rehwinkel, Ruperto Carola wants to gain a scientist for the Heidelberg location who is recognized in the scientific community as a top-level representative of his research field. Besides the outstanding scientific qualifications of candidates for a Humboldt Professorship, a crucial factor is the strategy of the universities, which are expected to offer the researchers and their teams lasting prospects in Germany. By appointing Jan Rehwinkel, Heidelberg University and its Medical Faculty Heidelberg aim to supplement the broad expertise of Heidelberg life sciences in the fields of cellular immunology, engineering of molecular systems, molecular materials sciences and systems biology by the biochemistry of innate immunity. That is also intended to link up with research in the field of synthetic immunology, which is carried out in the new SynthImmune Cluster of Excellence. Prof. Rehwinkel’s work will open up new, complementary perspectives for reinforcing vaccine development, infection control and cancer immunotherapy, which are to be rapidly translated into clinical applications in close cooperation between basic research and translational research. 

Jan Rehwinkel studied biology at Heidelberg University where he also earned his doctorate in 2007. For his doctoral thesis on issues connected with RNA biology he pursued research at the European Molecular Biology Laboratory (EMBL) in Heidelberg. As a postdoctoral researcher he concentrated on exploring what role nucleic acids play in innate immunity and how RNA viruses are detected by sensors in the innate immune system. After research positions in Heidelberg and London (UK) the scientist in 2012 accepted a professorship in innate immunology at the University of Oxford, where he set up his own research group.

International academics who have a leading position worldwide in their field can be nominated for the Alexander von Humboldt Professorship. The intention is that – with the support of the highly endowed prize – their research studies can make a sustainable contribution to the international competitiveness of Germany as a research location. The prize money is meant for financing the first five years of their work. Up to ten professorships can be granted annually. After successful appointment negotiations with the respective universities, the prizes will be awarded next year.

Further Information

Our latest News

discover more
Universität Heidelberg Succeeds with Three Funding Applications for Collaborative Research Centres

Universität Heidelberg Succeeds with Three Funding Applications for Collaborative Research Centres

DFG grants around 35,6 million euros to extend two transregional consortia and one CRC Heidelberg University has been successful in the current approval round of the German Research Foundation (DFG) with three grant applications for major research consortia. In the life sciences and medicine, a Collaborative Research Centre working on the Wnt signaling pathway will […]

How bacteria can cause cancer: Research award for Jens Puschhof

How bacteria can cause cancer: Research award for Jens Puschhof

Jens Puschhof, junior research group leader at the German Cancer Research Center (DKFZ), receives the 2026 Research Award from the Peter and Traudl Engelhorn Foundation. The foundation honors the young scientist for his research on the influence of bacteria on the development and spread of cancer. Jens Puschhof is analyzing the close interactions between tumor […]

PEPperPRINT GmbH: EU-Funded TRANSCAN-3 Project Marks Key Milestones in Personalized Immunotherapy for Esophageal Cancer

PEPperPRINT GmbH: EU-Funded TRANSCAN-3 Project Marks Key Milestones in Personalized Immunotherapy for Esophageal Cancer

The TRANSCAN-3 project (T-PLEX EAC), funded by the European Union, is approaching the end of its second year with significant progress in developing personalized adoptive T cell therapies for patients with esophageal adenocarcinoma (EAC). EAC remains the most common esophageal cancer in Western populations, and despite advances in chemotherapy, radiotherapy, and surgery, only around 20% […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp